دورية أكاديمية
أعرض في EDS

Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease.

التفاصيل البيبلوغرافية
العنوان: Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease.
المؤلفون: Krittanawong C; Cardiology Division, NYU Langone Health and NYU School of Medicine, New York, NY. Electronic address: Chayakrit.Krittanawong@nyulangone.org., Escobar J; Division of Cardiology, Harlem Cardiology, New York, NY., Virk HUH; Harrington Heart & Vascular Institute, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, Ohio., Alam M; The Texas Heart Institute., Virani S; Section of Cardiology, Baylor College of Medicine, Houston, Texas; The Aga Khan University, Karachi, Pakistan; Baylor College of Medicine, Houston, Texas., Lavie CJ; John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, La., Narayan KMV; Emory Global Diabetes Research Center, Woodruff Health Sciences Center and Emory University, Atlanta, Ga., Sharma R; Department of Medicine/Cardiology, The Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée Henry R. Kravis Cardiovascular Health Center, Icahn School of Medicine at the Mount Sinai Hospital, Mount Sinai Heart, New York, NY.
المصدر: The American journal of medicine [Am J Med] 2024 Mar; Vol. 137 (3), pp. 202-209. Date of Electronic Publication: 2023 Nov 21.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0267200 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-7162 (Electronic) Linking ISSN: 00029343 NLM ISO Abbreviation: Am J Med Subsets: MEDLINE
أسماء مطبوعة: Publication: New York, NY : Excerpta Medica
Original Publication: New York, Donnelly.
مواضيع طبية MeSH: Peripheral Arterial Disease*/complications , Hypertension*/complications , Diabetes Mellitus*, Humans ; Aged ; Platelet Aggregation Inhibitors/therapeutic use ; Clopidogrel ; Lower Extremity ; Risk Factors ; Life Style
مستخلص: Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
التعليقات: Comment in: Am J Med. 2024 Jul;137(7):e136-e137. doi: 10.1016/j.amjmed.2024.03.022. (PMID: 38942492)
فهرسة مساهمة: Keywords: Lifestyle approach; Lifestyle medicine; PAD; Peripheral artery disease
المشرفين على المادة: 0 (Platelet Aggregation Inhibitors)
A74586SNO7 (Clopidogrel)
تواريخ الأحداث: Date Created: 20231119 Date Completed: 20240227 Latest Revision: 20240723
رمز التحديث: 20240723
DOI: 10.1016/j.amjmed.2023.10.028
PMID: 37980970
قاعدة البيانات: MEDLINE
الوصف
تدمد:1555-7162
DOI:10.1016/j.amjmed.2023.10.028